Fusion Biopsy
DETECTION
FUSION BIOPSY
About Fusion Guided Biopsy
Fusion technology combines the benefits of MR imaging and real time ultrasound. MRI has the advantage of evaluating 100% of the prostate to look for areas suspicious for cancer. Using this information from the MRI, we fuse these findings withe the ultrasound machine results. This new fusion information can now target areas that may not be visualized during the standard biopsy.
About Fusion Guided Biopsy
Fusion technology combines the benefits of MR imaging and real time ultrasound. MRI has the advantage of evaluating 100% of the prostate to look for areas suspicious for cancer. Using this information from the MRI, we fuse these findings withe the ultrasound machine results. This new fusion information can now target areas that may not be visualized during the standard biopsy.
Advantages
Thorough Targeting
Can target areas that may be missed on through a standard biopsy.
In Office Care
Moves the biopsy from the MRI magnet to the urologists office.
Heightened Detection
Improved cancer detection in patients with a suspicious MRI.
Decreased Impact
Provides a possible decrease in un-needed biopsies.
Additional Tracking
Allows direct targeting and tracking of biopsy needles.
Complete Visualization
Visibility of central/transitional zone of the prostate which the standard biopsy does not sample.
Advantages
Thorough Targeting
Can target areas that may be missed on through a standard biopsy.
In Office Care
Moves the biopsy from the MRI magnet to the urologists office.
Heightened Detection
Improved cancer detection in patients with a suspicious MRI.
Decreased Impact
Provides a possible decrease in un-needed biopsies.
Additional Tracking
Allows direct targeting and tracking of biopsy needles.
Complete Visualization
Visibility of central/transitional zone of the prostate which the standard biopsy does not sample.
Increased Detection Capabilities
The NIH has reported that approximately 40% of men only have a cancer detected on a subsequent biopsy when MR/US fusion biopsies have been performed, compared to the repeated standard 12 core biopsy in which only 10% is detected in a large European prospective study. MRI offers the opportunity to evaluate the entire gland with positive and negative predictive values > 90%, detecting and ruling out clinically significant cancers (intermediate and high grade disease with volumes greater than 0.5 cc).
Schedule an Appointment Today
Schedule an Appointment Today
News
January 30, 2019
September 6, 2017
